Sunny Wang
ARTICLES BY THIS AUTHOR
- 7/1/2026
New advances in extended-release buprenorphine therapy for opioid use disorder
Across Canada, some jurisdictions have already approved or are working towards expanding the scope of certified pharmacists to include the administration of Sublocade. - 2/11/2026
Alcohol use disorder pharmacotherapy
High-risk alcohol use is associated with a variety of health, social and economic impacts, including acute intoxication and impaired judgment, and increased risks of cancer, dementia, cardiovascular and hepatic diseases. - 7/7/2025
Switching antidepressants
Unlike many other classes of medication, special care must be taken when switching antidepressants due to the potential for withdrawal symptoms. - 2/18/2025
Managing antipsychotic-induced extrapyramidal symptoms
Pharmacists should familiarize themselves with the EPS risk profile of the various antipsychotic agents to help inform management recommendations. - 7/4/2024
Tackling polypharmacy in psychiatry
Close to 60% of patients in U.S. national ambulatory survey were prescribed two or more psychotropic medications in 2005, a sharp rise from the 42.6% seen in 1996. - 3/19/2024
Tapering benzodiazepines
Patients are often unaware that benzodiazepines are the reason for their daytime drowsiness or lack of energy when combined with some of their other medications, and that a taper can lead to increased alertness, focus and energy throughout the day.
